These were combined with paired TCRs from 9,341 CD4+ and 4,935 CD8+ intratumoral T cells (50.4% and 53.9%, respectively, of all tumor T cells with RNA data) from the same patients (7). This evidence concerns the gene CD4 and neoplasm.